Home Newsfeeds Exane BNP Paribas Upgrades Beauty Health to Neutral

Exane BNP Paribas Upgrades Beauty Health to Neutral

Exane BNP Paribas analyst Navaan Ty upgrades Beauty Health (NASDAQ:SKIN) from Underperform to Neutral.

byBenzinga Newsdesk

March 20, 2023

1 minute read

Exane BNP Paribas analyst Navaan Ty upgrades Beauty Health (NASDAQ:SKIN) from Underperform to Neutral.

News

ChargePoint Launches Updated Mobile App To Celebrate the EV Charging Network Reaching One Million Quarterly Active Drivers

By Benzinga Newsdesk

November 8, 9:07 AM

ChargePoint (NYSE:CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), announced today the milestone of one million quarterly active drivers on its network. To celebrate the occasion,

CHPT

Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target

By Priya Nigam

April 10, 11:25 AM

Shares of Incyte Corporation (NASDAQ: INCY) recovered last week, after having been under pressure on setbacks to its LIMBER Program.

INCY

Amylyx Pharmaceuticals Announces Publication Of Data Showing The Effect Of AMX0035 On Plasma Neuroinflammatory Biomarkers In ALS

By Benzinga Newsdesk

December 4, 10:06 AM

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced the publication of analyses performed on neuroinflammatory biomarkers using plasma samples from participants with amyotrophic lateral

AMLX

Energy Vault Selects Plug Power To Supply 8 MW Of Hydrogen Fuel Cells As Part Of Hybrid Microgrid Back-Up System For PG&E And The City Of Calistoga

By Happy Mohamed

June 9, 10:05 AM

Energy Vault to Participate at Plug's Analyst Day on June 14, 2023 Innovative design combining Plug Fuel Cells with Lithium-Ion Batteries Will Displace Diesel Generators to Power Microgrid During

PLUG

Exane BNP Paribas Upgrades Beauty Health to Neutral

Related Posts

ChargePoint Launches Updated Mobile App To Celebrate the EV Charging Network Reaching One Million Quarterly Active Drivers

Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target

Amylyx Pharmaceuticals Announces Publication Of Data Showing The Effect Of AMX0035 On Plasma Neuroinflammatory Biomarkers In ALS

Energy Vault Selects Plug Power To Supply 8 MW Of Hydrogen Fuel Cells As Part Of Hybrid Microgrid Back-Up System For PG&E And The City Of Calistoga